AOTI Inc
AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incor… Read more
AOTI Inc (AOTI) - Net Assets
Latest net assets as of June 2025: GBX17.74 Million GBX
Based on the latest financial reports, AOTI Inc (AOTI) has net assets worth GBX17.74 Million GBX as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX54.38 Million) and total liabilities (GBX36.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX17.74 Million |
| % of Total Assets | 32.63% |
| Annual Growth Rate | 307.08% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 747.3 |
AOTI Inc - Net Assets Trend (2021–2024)
This chart illustrates how AOTI Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AOTI Inc (2021–2024)
The table below shows the annual net assets of AOTI Inc from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX17.44 Million | +395.07% |
| 2023-12-31 | GBX-5.91 Million | -273.18% |
| 2022-12-31 | GBX3.41 Million | +1221.42% |
| 2021-12-31 | GBX258.29K | -- |
Equity Component Analysis
This analysis shows how different components contribute to AOTI Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1754998400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX1.00K | 0.01% |
| Other Components | GBX35.09 Million | 201.17% |
| Total Equity | GBX17.44 Million | 100.00% |
AOTI Inc Competitors by Market Cap
The table below lists competitors of AOTI Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
STANDARD CHARTERED BOTSWANA LIMITED
XBOT:SCBB-EQO
|
$5.95K |
|
185190
KO:185190
|
$5.95K |
|
Carbon Revolution Public Limited Company Warrant
NASDAQ:CREVW
|
$5.95K |
|
Blencowe Resources Plc
LSE:BRES
|
$5.95K |
|
China Networks International Holdings Ltd
PINK:CNWHF
|
$5.94K |
|
Banco BMG S.A.
SA:BMGB10
|
$5.93K |
|
MTRE3F
SA:MTRE3F
|
$5.93K |
|
OceanaGold Philippines Inc
PSE:OGP
|
$5.92K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AOTI Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -5,910,813 to 17,441,000, a change of 23,351,813.
- Net loss of 1,756,000 reduced equity.
- Other factors increased equity by 25,107,813.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-1.76 Million | -10.07% |
| Other Changes | GBX25.11 Million | +143.96% |
| Total Change | GBX- | % |
Book Value vs Market Value Analysis
This analysis compares AOTI Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 204.29x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 13794.86x to 204.29x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | GBX0.00 | GBX33.50 | x |
| 2022-12-31 | GBX0.03 | GBX33.50 | x |
| 2023-12-31 | GBX-0.06 | GBX33.50 | x |
| 2024-12-31 | GBX0.16 | GBX33.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AOTI Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.01%
- • Asset Turnover: 1.48x
- • Equity Multiplier: 2.27x
- Recent ROE (-10.07%) is below the historical average (1.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -33.61% | -9.76% | 0.59x | 5.84x | GBX-112.65K |
| 2022 | 51.02% | 19.65% | 0.95x | 2.74x | GBX1.40 Million |
| 2023 | 0.00% | -18.64% | 2.08x | 0.00x | GBX-7.60 Million |
| 2024 | -10.07% | -3.01% | 1.48x | 2.27x | GBX-3.50 Million |
Industry Comparison
This section compares AOTI Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $78,827,469
- Average return on equity (ROE) among peers: -42.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AOTI Inc (AOTI) | GBX17.74 Million | -33.61% | 2.06x | $5.95K |
| Belluscura Plc (BELL) | $1.20 Million | -81.38% | 0.34x | $366.21 |
| Creo Medical Group PLC (CREO) | $59.80 Million | -36.29% | 0.28x | $8.34K |
| Inspiration Healthcare Group PLC (IHC) | $28.97 Million | -20.83% | 0.69x | $2.87K |
| Intelligent Ultrasound Group PLC (IUG) | $12.16 Million | -24.53% | 0.32x | $5.19K |
| NIOX Group PLC (NIOX) | $440.90 Million | -11.32% | 0.11x | $31.53K |
| Rua Life Sciences PLC (RUA) | $7.39 Million | 0.01% | 0.25x | $1.01K |
| Surgical Innovations Group plc (SUN) | $1.37 Million | -123.23% | 1.08x | $510.74 |